Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells.

Sarcomas are rare, mesenchymal tumors, representing about 10-15% of all childhood cancers. GD2 is a suitable target for chimeric antigen receptor (CAR) T-cell therapy due to its overexpression in several solid tumors. In this preclinical study, we investigated the potential use of iCasp9.

Artificial fingerprints engraved through block-copolymers as nanoscale physical unclonable functions for authentication and identification.

Besides causing financial losses and damage to the brand's reputation, counterfeiting can threaten the health system and global security. In this context, physical unclonable functions (PUFs) have been proposed to overcome limitations of current anti-counterfeiting technologies. Here, we report on artificial fingerprints that can be directly engraved on a wide range of substrates through self-assembled block-copolymer templating as nanoscale PUFs for secure authentication and identification.

Lack of agreement among analysers of infrared thermal images in the temperature of eye regions in sheep.

Infrared thermography (IRT) is a non-invasive method to estimate body temperature in many animal species. The eye has been indicated as the ideal region for IRT, potentially serving as an early indicator of variations in body temperature triggered by various events and stimuli. Studies are being conducted to understand sources of variation in IRT temperature of the eye and develop comprehensive guidelines for veterinary medicine and animal production purposes.

Reappraisal of soft tissue myoepithelial tumors by DNA methylation profiling reveals an epigenetically distinct group of mostly fusion-driven neoplasms.

Soft tissue myoepithelial tumors (METs) are diagnostically challenging tumors that require careful histologic and immunohistochemical characterization for accurate classification. Nearly half of METs show recurrent EWSR1 or FUS gene rearrangements with a diverse set of fusion partners. The diversity of fusion partners and lack of known driver abnormalities in many cases raises the question of whether METs represent a uniformly distinct tumor entity.